Effect of cloned inhibitor-resistant TEM β-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin/clavulanate

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 5, 2007, Pages 1151-1154

  Tristram, Stephen G ^a   Burdach, Jonathan G ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

H. influenzae; IRTs; Susceptibility

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE TEM 1; HYDROLASE; INHIBITOR RESISTANT TEM BETA LACTAMASE; INHIBITOR RESISTANT TEM BETA LACTAMASE 2; INHIBITOR RESISTANT TEM BETA LACTAMASE 4; INHIBITOR RESISTANT TEM BETA LACTAMASE 5; PENICILLIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PROMOTER REGION; STRAIN DIFFERENCE;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CLONING, MOLECULAR; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; MUTATION; PROMOTER REGIONS (GENETICS);

EID: 35448987053     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm311     Document Type: Article

References (18)

1. Hoban D, Felmingham D. The PROTEKT surveillance study: Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50 Suppl S1: 49-59.
2. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemopilus influenzae. Clin Microbiol Rev 2007; 20: 368-89.
3. Nicolas-Chanoine MH. Inhibitor-resistant β-lactamases. J Antimicrob Chemother 1997; 40: 1-3.
4. Chaibi EB, Sirot D, Paul G et al. Inhibitor-resistant TEM β-lactamases: Phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother 1999; 43: 447-58.
5. Ubukata K, Shibasaki Y, Yamamoto K et al. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45: 1693-9.
6. Dabernat H, Delmas C, Seguy M et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002; 46: 2208-18.
7. TEM genes and promoters in H. influenzae. J Antimicrob Chemother 2005; 56: 481-4.
8. TEM promoter variant. J Antimicrob Chemother 2006; 58: 183-5.
9. Tristram SG. Effect of extended spectrum β-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins. J Antimicrob Chemother 2003; 51: 39-43.
10. Jacoby G, Bush K. Amino acid Sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant β-lactamases. 2002. http://www.lahey.org/studies (3 April 2007, date last accessed).
11. Blazquez J, Baquero M, Canton R et al. Characterization of a new TEM type β-lactamase resistant to clavulanate, sulbactam and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother 1993; 37: 2059-63.
12. TEM genes and their promoters. Antimicrob Agents Chemother 2000; 44: 3232-4.
13. Bozdogan B, Tristram SG, Appelbaum PC. Combination of altered PBPs and expression of cloned extended spectrum p-lactamases confers cefotaxime resistance in Haemophilus influenzae. J Antimicrob Chemother 2006; 57: 747-9.
14. Tristram S, Davidson R, Pitout M. TEM-15 ESBL and altered PBP3 in multi-resistant strains of H. parainfluenzae. In: Final Program and Book of Abstracts of the Antimicrobials 2004 Conference, Melbourne, Australia, 2007. Australian Society for Antimicrobials, Australia.
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2007.
16. Andrews JM. BSAC standardized disc susceptibility method (version 5). J Antimicrob Chemother 2006; 58: 511-29.
17. Jacobs MR, Felmingham D, Appelbaum PC et al. The Alexander Project 1998-2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229-46.
18. Farrell D, Morrissey J, Bakker S et al. Global distribution of TEM-1 and ROB-1 β-lactamases in Haemophilus influenzae. J Antimicrob Chemother 2005; 56: 773-6.